You are here

  • Home
  • Archive
  • Volume 11, Issue 5
  • Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

Citation Tools

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kumar A, Ramani V, Bharti V, et al
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
Journal for ImmunoTherapy of Cancer 2023;11:e006019. doi: 10.1136/jitc-2022-006019